Impact of preoperative prostate magnetic resonance imaging on the surgical management of high-risk prostate cancer

Janet Baack Kukreja(The University of Texas MD Anderson Cancer Center), Brian F. Chapin(The University of Texas MD Anderson Cancer Center)

Prostate Cancer and Prostatic Diseases

September 9, 2019

10.1038/s41391-019-0171-0

Cited by 23

Related Papers

NCCN Guidelines® Insights: Prostate Cancer, Version 1.2023.

|PubMed|2022|172

Diagnostic Performance and Safety of Positron Emission Tomography with 18F-rhPSMA-7.3 in Patients with Newly Diagnosed Unfavourable Intermediate- to Very-high-risk Prostate Cancer: Results from a Phase 3, Prospective, Multicentre Study (LIGHTHOUSE)

|European Urology|2023|90

Diagnostic Performance and Safety of <sup>18</sup> F-rhPSMA-7.3 Positron Emission Tomography in Men With Suspected Prostate Cancer Recurrence: Results From a Phase 3, Prospective, Multicenter Study (SPOTLIGHT)

|The Journal of Urology|2023|65